Galactomannan and Computed Tomography-Based Preemptive Antifungal Therapy in Neutropenic Patients at High Risk for Invasive Fungal Infection: A Prospective Feasibility Study - Concepedia

Concepedia

Publication | Open Access

Galactomannan and Computed Tomography-Based Preemptive Antifungal Therapy in Neutropenic Patients at High Risk for Invasive Fungal Infection: A Prospective Feasibility Study

DOI Full Paper Access

591

Citations

35

References

2005

Year

Johan Maertens, Koen Theunissen, G. Verhoef, Johny Verschakelen, Katrien Lagrou, Eric Verbeken, A. Wilmer, Jan Verhaegen, M. Boogaerts, Johan Van Eldere

Clinical Infectious Diseases

Abstract

Preemptive therapy based on enzyme immunoassay and HRCT reduced the exposure to expensive and potentially toxic drugs and offered effective antifungal control, but it failed to detect non-Aspergillus IFI.

References

	Year	Citations
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis Raoul Herbrecht, David W. Denning, Thomas F. Patterson, New England Journal of Medicine	2002	3.3K
Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus John Rex, Ben de Pauw, John E. Bennett, Clinical Infectious Diseases Diagnostic MycologyImmunologyDiagnosisPathologyClinical Mycology	2002	2.3K
2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer Walter T. Hughes, Donald Armstrong, Gerald P. Bodey, Clinical Infectious Diseases	2002	2K
Epidemiology and Outcome of Mould Infections in Hematopoietic Stem Cell Transplant Recipients Kieren A. Marr, Rachel A. Carter, Fulvio Crippa, Clinical Infectious Diseases	2002	1.4K
Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia Thomas J. Walsh, Robert W. Finberg, Carola Arndt, New England Journal of Medicine	1999	1.2K
Voriconazole Compared with Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Neutropenia and Persistent Fever Thomas J. Walsh, Peter G. Pappas, Drew J. Winston, New England Journal of Medicine	2002	985
Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors Kieren A. Marr, Rachel A. Carter, Michael Boeckh, Blood	2002	950
Caspofungin versus Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Persistent Fever and Neutropenia Thomas J. Walsh, Hedy Teppler, Gerald R. Donowitz, New England Journal of Medicine	2004	917
Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia Philip A. Pizzo, K.J. Robichaud, Fred A. Gill, The American Journal of Medicine Prolonged FeverAntifungal AgentAntibioticsAntifungal AgentsMedicine	1982	868
Efficacy and Safety of Voriconazole in the Treatment of Acute Invasive Aspergillosis David W. Denning, Patricia Ribaud, Nöel Milpied, Clinical Infectious Diseases Antifungal AgentAntifungal AgentsAcute IaMedicinal FungiAcute Invasive Aspergillosis	2002	842

Page 1